iiinova — where your digital self keeps evolving

D2R | DNA to RNA @d2rmcgill.bsky.social · 21h

The best mentors don't just shape careers. They inspire others to mentor. Prof. Yann Joly reflects on Robert Sladek's legacy and how he's carrying those lessons forward through a new mentorship initiative. 🔗 mcgill.ca/dna-to-rna/a... @genomicsandpolicy.bsky.social

mcgill.ca

A Legacy of Mentorship

When Prof. Yann Joly talks about the late Prof. Robert Sladek, he does not start with genomics, research achievements or scientific breakthroughs. Instead, he talks about conversations. About humour. ...

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 01/10/2026

✨ #D2RTraineeSpotlight: Julia Fulber From #RNA therapeutic manufacturing and quality control to strengthening global RNA production capacity, Julia is making an impact across multiple D2R-supported projects while completing her PhD. 👉 mcgill.ca/dna-to-rna/a...

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 30/09/2026

🧡 On the National Day for Truth and Reconciliation, Tamara Hansen, D2R's Associate Director, Indigenous Health Research, reflects on what reconciliation means in research. #ResearchCanBeReconciliation youtube.com/shorts/PhC4k...

youtube.com

National Day for Truth and Reconciliation

YouTube video by D2R | DNA to RNA

011

D2R | DNA to RNA @d2rmcgill.bsky.social · 22/09/2026

🔊 #D2RProjectSpotlight Led by Maria Vera Ugalde (McGill), this project explores antisense oligonucleotides, a novel RNA-based approach to help restore cells' natural defense systems and combat neurodegenerative diseases like ALS and Alzheimers. mcgill.ca/dna-to-rna/f...

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 21/09/2026

✨ #D2RTraineeSpotlight 🧠 Meet Vishvak (McGill), a D2R Scholar and PhD student in #ComputerScience. His research uses #AI to analyze single-cell and spatial #genomics data, helping us better understand how cells develop, change, and respond to therapies. 👉 www.mcgill.ca/dna-to-rna/a...

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 18/09/2026

🔊 #D2RProjectSpotlight Led by Suhad Ali (@rimuhc.bsky.social ) this project is validating a new #RNA-based therapy for triple-negative #breastcancer, an aggressive cancer with limited treatment options. 🔗 mcgill.ca/dna-to-rna/f...

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 17/09/2026

🧡 What does #ResearchCanBeReconciliation mean? We spoke with Indigenous artist Summer (Niibin) Taylor about the inspiration behind this year's D2R design for the National Day for Truth and Reconciliation. 📖 Read the Q&A: www.mcgill.ca/dna-to-rna/a...

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 10/09/2026

🎉 Congratulations to the recipients of the 2026 D2R Scholar Awards! This year, D2R is supporting 30 outstanding Master's and Doctoral students conducting innovative #RNAResearch at @mcgill.ca, @uottawa.ca, UBC, and @usherbrooke.bsky.social. 🔗 www.mcgill.ca/dna-to-rna/c...

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 08/09/2026

🔬 New funding opportunity from D2R: ELSI of Genomics Catalyst Grants Support research examining the ethical, legal, social, policy, and equity dimensions of genomic medicine while building new collaborations across disciplines. 📅 LOI deadline: Oct. 15, 2026 🔗 www.mcgill.ca/dna-to-rna/f...

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 03/08/2026

📢 New funding opportunity The D2R Strategic Initiative on Cancer Vaccines will support multidisciplinary teams advancing neoantigen-based cancer vaccines toward clinical implementation, including first-in-human studies. 📅 LOI deadline: Sept. 1, 2026 (9 a.m. ET) 🔗 www.mcgill.ca/dna-to-rna/f...

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 09/07/2026

🔊 #D2RProjectSpotlight: mRNA therapy for CLN3 Batten disease led by Professor Carl Ernst (@mcgillu) 🔗 Learn more here: buff.ly/yELbB3f

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 07/07/2026

🔊 #D2RProjectSpotlight: From Bench to Bedside: RNA and AAV Gene Therapies for Diffuse Midline Gliomas led by Professor Nada Jabado (@mcgillu) 🔗 Learn more here: buff.ly/GtdyVpA

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 30/06/2026

🔊 #D2RProjectSpotlight: LNP/mRNA Therapy for Sickle Cell Disease led by Professor Anastasia Nijnik (@mcgillu) 🔗 Learn more here: buff.ly/ezQMPOB

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 25/06/2026

#D2RTraineeSpotlight ✨ Trainee Spotlight: Michael Trinh (@McGillU) 👉 Read the full interview to learn more about Michael’s journey and research: buff.ly/Hi9WRgf

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 23/06/2026

🔊 #D2RProjectSpotlight: From Trial to Gene Therapy: Restoring Differentiation in IDH-Mutant Glioma led by Professor Charles Couturier (@mcgillu) 🔗 Learn more here: buff.ly/OiMiCTi

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 17/06/2026

#D2RTraineeSpotlight ✨ Trainee Spotlight: Kate Bornais (@McGillU)👉 Read the full interview to learn more about Kate’s journey and research: buff.ly/muw8Ne1

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 07/05/2026

Now in @natchem.nature.com: Antibodies dominate drug development—but they’re big, costly, and can trigger immune reactions. #McGill professors Hanadi Sleiman & Maureen McKeague introduce Alenomers: barcoded aptamers with antibody‑level chemical diversity, screenable at massive scale buff.ly/BKKN4zS

031

D2R | DNA to RNA @d2rmcgill.bsky.social · 07/05/2026

🧬#D2RProjectSpotlight: Switchable self-amplifying RNA: Safe, Selective, and Programmable Therapeutic Expression led by Prof. Maureen McKeague with collaborator Prof. Anna Blakney 🔗Learn more here: buff.ly/hlfhhvb

030

D2R | DNA to RNA @d2rmcgill.bsky.social · 05/05/2026

🧬#D2RProjectSpotlight: Targeting miRNAs in Embryonal Brain Tumors (@mcgillu Prof. Jacek Majewski) This project will study the molecular effects of this genome rearrangement and explore the use of microRNA inhibitors – sponges – to counteract the oncogenic changes buff.ly/309J3d2

030

D2R | DNA to RNA @d2rmcgill.bsky.social · 04/05/2026

D2R awards nearly $6M in funding to support 4 Translational Impact research projects focused on advancing RNA-based therapies for cancer and rare genetic diseases. 🔗 Learn more about these projects and the funded professors here: buff.ly/TPzPPdH

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 23/04/2026

And that's a wrap on Day 1 of the #D2RSymposium2026 🎉 All of today’s sessions highlighted that the research, both within the D2R community and beyond, is full of exciting developments. Stay tuned for even more on Day 2 tomorrow!

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 23/04/2026

#D2RSymposium2026 is underway! Sharing a few highlights from the action 📸 Tune into our LinkedIn for all the updates! 🧬 #RNATherapeutics

020

D2R | DNA to RNA @d2rmcgill.bsky.social · 23/04/2026

🌟 The #D2RSymposium2026 is officially underway! Today and tomorrow we will be posting highlights of the event on our LinkedIn including inspiring talks, innovative research, trainee presentations, and more in #RNAtherapeutics.💡Big MERCI to all our sponsors! buff.ly/YzOWyGL

mcgill.ca

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 20/03/2026

🌟D2R is seeking a strategic and collaborative leader to join our team as Associate Director, Indigenous Health Research for D2R. This role supports Indigenous-led health research, fosters strong partnerships with Indigenous communities & organizations and more! Learn more: buff.ly/zxV3Uxx

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 05/03/2026

🔊 #D2RProjectSpotlight: D2R - Health Data Science (D2R-HeDS) platform 💡 Scientific Director: Guillaume Bourque (@McGillu) 🔗 Learn more: buff.ly/qDphDDy #RNA #RNATherapy #RNAResearch

100

D2R | DNA to RNA @d2rmcgill.bsky.social · 03/03/2026

#D2RProjectSpotlight: End to end sequencing platform for RNA therapeutics quality control (EESPRNATQC) Scientific Director: Ioannis Ragoussis (@mcgillu)🔗 Learn more here: buff.ly/zhzGYc7

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 24/02/2026

🔊 #D2RProjectSpotlight: Centre for Applied Nanomedicine (CAN)💡 Scientific Director: Janusz Rak (RI-MUHC)🧬 Centre for Applied Nanomedicine (CAN) is a place/platform where specialized instruments measure, observe, and characterize myriads of small objects known as nanoparticles 🔗 buff.ly/Hv3NYJV

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 23/02/2026

#BlackHistoryMonth D2R held a webinar on Anti-Black Racism in Health Research. It examined how slavery and anti-Black racism in Canada shaped inequities in health research & the systemic barriers that continue to influence scientific inquiry and health outcomes today. Watch here: buff.ly/uaYFjZA

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 19/02/2026

#D2RProjectSpotlight: RNA therapies for the treatment of a rare neurological disease led by Jo Anne Stratton (@mcgillu) This project aims to understand how RNA-based therapies can be optimized to target Schwann cells, the major cell type affected in Neurofibromatosis type 2.🔗 buff.ly/QYf2Kfg

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 17/02/2026

🔊 #D2RProjectSpotlight: RNA therapeutics to block USP15-driven neuroinflammation in the brain led by Philippe Gros (@mcgillu) this project aims to test the capacity of these USP15 modalities to block neuroinflammation in vivo following delivery to the brain. Learn more: buff.ly/P0QfkgL

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 13/02/2026

🔊 #D2RProjectSpotlight: mRNA Therapy to Prevent Liver Disease Progression in Zellweger Spectrum Disorder led by Nancy Braverman (@McGillu) ZSD is a rare genetic disorder, most patients harbor mutations in PEX1 gene. This project aims to restore PEX1 function. Learn more: buff.ly/3Y93ZQY

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 10/02/2026

🔊 #D2RProjectSpotlight: Aptamer-short hairpin RNA conjugation for gene therapy against HIV led by Anne Gatignol (Jewish General Hospital)🧬This research aims to support a more effective procedure in which a person's own cells are modified to make them resistant to HIV.🔗 buff.ly/WudYn1G

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 06/02/2026

🔊 #D2RProjectSpotlight: Lipid Nanoparticles for Nasal mRNA Vaccines💡 Led by Larry Lands (RI-MUHC) 🧬 This project explores delivering RNA vaccines through a nose spray. This nasal method is not only more convenient but could offer better protection for the lungs. 🔗 Learn more: buff.ly/raSze21

020

D2R | DNA to RNA @d2rmcgill.bsky.social · 04/02/2026

On #WorldCancerDay, we are reminded why research matters. D2R supports research across many types of #cancer, because whether they affect millions or thousands, every diagnosis deserves attention. #cancerresearch #cancerawareness #knowledgetocure

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 03/02/2026

🔊 #D2RProjectSpotlight: 3’UTR engineering for next-generation T cell mRNA therapeutics led by Thomas Duchaine (@mcgillu) This project aims to improve cancer immunotherapies by designing “smart” RNA switches that control how long therapeutic mRNAs stay active in immune cells. buff.ly/iyMZTzA

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 29/01/2026

🔊 #D2RProjectSpotlight: Development of RNA therapeutics against USP15-dependent neuroinflammation led by Philippe Gros, PhD🧬This project aims to develop inhibitors of USP15 which can dampen neuroinflammation using an RNA therapeutics approach. 🔗 Learn more: buff.ly/o3CRrRl

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 27/01/2026

🔊 #D2RProjectSpotlight: Targeting MET exon 14 skipping variant in the early metastatic dissemination in lung cancer 🧬 Led by Morag Park (@mcgillgci.bsky.social) this project aims a novel therapy using targeted molecules designed to block this mutation. 🔗 buff.ly/VfPel6h

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 23/01/2026

#D2RProjectSpotlight: Injectable Hydrogel/mRNA-LNP Platform for In Vivo CAR-T Cell Engineering 🧬Led by Guojun Chen (@McGillu) this project aims to accelerate the development of next-generation immunotherapies buff.ly/Xa2wnaT

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 20/01/2026

#D2RProjectSpotlight: Transient CAR-T Cell engineering🧬Led by Taha Azad (@USherbrooke) this project aims to produce safe & effective CAR-Ts, and help accelerate RNA-based cell therapy development buff.ly/Tsz4eBD

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 15/01/2026

#D2RProjectSpotlight: Development of a new blood test to track treatment success and to detect melanoma returning early🧬Led by Ian Watson (@mcgillu) this project aims to improve care for melanoma patients. buff.ly/7cVwU65

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 13/01/2026

🔊#D2RProjectSpotlight: From #RNA to personalized #lungdisease treatment 🧬Led by David Langlais (@mcgill.ca), this project aims to identify blood markers for earlier diagnosis and personalized treatment of interstitial lung disease (ILD). 🔗https://shorturl.at/yXxOO #RNA #RNAtherapies

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 13/01/2026

🎯 Want to stay connected to the D2R community? 📩 Subscribe to our newsletter for updates on funded research, events, data science news, EDI, and trainee opportunities: shorturl.at/KynG2 👉 Follow us here and on X, LinkedIn and YouTube for the latest from #D2RMcGill

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 22/12/2025

❄️ Happy Holidays from DNA to RNA! Wishing you all a festive holiday season filled with love and laughter. ❄️ ☃️ Communication channels will not be monitored over the holidays (Dec 24- Jan 4), see you in the new year!

000

Reposted by D2R | DNA to RNA

D2R | DNA to RNA @d2rmcgill.bsky.social · 19/11/2025

🧠 ❤️Join D2R for an EDI seminar about mental health in highly performant spaces in honour of the International Day for Persons with Disabilities 📅 December 3 🕐12–1 PM EST 📍Via Zoom 🔗 Register here: buff.ly/t1gvjy8

001

D2R | DNA to RNA @d2rmcgill.bsky.social · 19/11/2025

001

D2R | DNA to RNA @d2rmcgill.bsky.social · 11/11/2025

Join D2R for the next session of the D2R Investor Series with Inès Holzbaur, an experienced investor who will demystify the industry. 📅 28 November 2025 🕚 11:00 –1:00 📍Attend in person or via Zoom. Register here: buff.ly/tcFaGmP #Startups #Investing

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 07/11/2025

💡 Curious about how D2R is turning its Equity, Diversity, and Inclusion (EDI) vision into action? D2R’s EDI Action Plan was developed through a collaborative process, and outlines key initiatives across three key focus areas 🔗 Learn more:

buff.ly

D2R's EDI Action Plan

D2R’s EDI Action Plan was developed through a collaborative process involving equity-deserving groups, researchers, staff, and partners, with the goal of transforming good intentions into meaningful…

010

D2R | DNA to RNA @d2rmcgill.bsky.social · 06/11/2025

🧬 D2R invests over $5.3 million in research and $3.9 million in training to advance RNA innovation across Canada over the next two years. 🔗 Foundational Projects | Cycle 2: buff.ly/rDRhJ85 🔗 Research in Motion Projects | Cycle 2: buff.ly/ZCjFser #RNAResearch #Innovation

000

D2R | DNA to RNA @d2rmcgill.bsky.social · 05/11/2025

🧬 Professor Carl Ernst and his team are leading a groundbreaking RNA therapy project aimed at treating Schinzel-Giedion Syndrome supported by D2R’s Translational Impact Research program. 🔗 Learn more: buff.ly/0X51szG #RareDisease #RNAtherapy @mcgillscience.bsky.social @theneuro.bsky.social

001

D2R | DNA to RNA @d2rmcgill.bsky.social · 30/10/2025

🎉 We are proud to launch our Equity, Diversity, and Inclusion (EDI) Action Plan! ✨EDI is at the core of D2R’s vision, and the document outlines our current and upcoming EDI initiatives across three key focus areas. Read the Action Plan now: buff.ly/bEybZGg

000